The document discusses the challenges and hopes of individuals suffering from severe medical conditions and the innovative technologies being developed to assist them.

Anne Nitzer's Story:

Anne Nitzer suffers from locked-in syndrome following a stroke, leaving her fully conscious but unable to move or communicate.

Her family struggles with understanding her needs and emotions, relying on rudimentary communication methods like blinking.

Researchers at Berlin’s Charité hospital, led by Professor Surjo Soekadar, are developing neurotechnology to help Anne communicate using eye movements and brain-computer interfaces.

The technology aims to interpret Anne's eye movements to perform simple tasks, offering a glimmer of hope for better communication.

Oskar Zlamala's Battle with AMD:

Oskar Zlamala suffers from age-related macular degeneration (AMD), which threatens his vision.

Regular check-ups and injections at Vienna General Hospital help manage his condition, though the treatment is unpleasant and costly.

Advanced imaging and AI technology are used to assess the extent of fluid accumulation in his retina, allowing for more precise and less invasive treatment.

Guido Schulze's Rehabilitation:

Guido Schulze, paralyzed on one side due to a brain tumor operation, is testing a hand exoskeleton controlled by his thoughts.

The exoskeleton, combined with a brain signal-reading cap, helps reorganize his brain to regain hand movement.

This technology, still in the prototype stage, offers hope for improved motor function through neuroplasticity.

Lilly Lohmann's Liver Transplant:

Lilly Lohmann received a life-saving liver transplant from her son, Thomas.

At Essen University Hospital, AI technology was used to precisely calculate the liver's size and ensure a successful transplant.

The AI's precision in differentiating liver tissue from other tissues significantly improved the chances of a successful operation.

The document highlights the transformative potential of AI and neurotechnology in medical treatments, offering new hope and improved quality of life for patients with severe conditions.